Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology.
Agnieszka OrzińskaAnna KluskaAneta BalabasMagdalena PiatkowskaMaria KuleckaJerzy OstrowskiMichal MikulaMarzena DębskaMałgorzata UhrynowskaKatarzyna GuzPublished in: Transfusion (2022)
The use of Ion AmpliSeq HD technology improves the prediction of feto-maternal incompatibility, increasing the sensitivity of BG/HPA NIPT and serving confirmation of the fetal DNA at the same workflow.